Exchange: NASDAQ·Updated 04:26 PM EST

LTGO Latigo Biotherapeutics Inc.

$13.00
$0.24
(1.81%)
Today
Closed $13.00
$0.00
(0.00%)
After Hours
Reported EarningsNov 5
Mkt Cap$861.89M
Vol267,166.00

About LTGO

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded by Bryan Moyer on November 20, 2018 and is headquartered in Thousand Oaks, CA.
36

Bearish Sentiment

How do you feel about LTGO?

Advertisement|Remove ads.